Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plcverified

FRLN

Price:

$6.49

Market Cap:

$28.28M

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in Phase 1/2 clinical trial for the treatment of Fabry disease; and FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease and is under Phase 1/2 clinical trial. In addition, it has research p...[Read more]

Industry

Biotechnology

IPO Date

2020-08-07

Stock Exchange

NASDAQ

Ticker

FRLN

The Current Ratio as of November 2024 (TTM) for Freeline Therapeutics Holdings plc (FRLN) is 1.95

According to Freeline Therapeutics Holdings plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.95. This represents a change of -17.14% compared to the average of 2.35 of the last 4 quarters.

Freeline Therapeutics Holdings plc (FRLN) Historical Current Ratio (quarterly & annually)

How has FRLN Current Ratio performed in the past?

The mean historical Current Ratio of Freeline Therapeutics Holdings plc over the last ten years is 6.42. The current 1.95 Current Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), FRLN's Current Ratio was at its highest in in the March 2021 quarter at 14.13. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

6.42

Median

6.20

Minimum

2.18

Maximum

13.72

Freeline Therapeutics Holdings plc (FRLN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Freeline Therapeutics Holdings plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 151.53%

Maximum Annual Current Ratio = 13.72

Minimum Annual Increase = -64.79%

Minimum Annual Current Ratio = 2.18

Quarterly (TTM)
Annual
YearCurrent RatioChange
20222.18-64.79%
20216.20-54.81%
202013.7291.64%
20197.16151.53%

Freeline Therapeutics Holdings plc (FRLN) Average Current Ratio

How has FRLN Current Ratio performed in the past?

The current Current Ratio of Freeline Therapeutics Holdings plc (FRLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.37

5-year avg

6.42

10-year avg

6.42

Freeline Therapeutics Holdings plc (FRLN) Current Ratio vs. Peers

How is FRLN’s Current Ratio compared to its peers?

Freeline Therapeutics Holdings plc’s Current Ratio is greater than CNS Pharmaceuticals, Inc. (1.82), greater than ZyVersa Therapeutics, Inc. (0.03), greater than eFFECTOR Therapeutics, Inc. (1.03), less than VectivBio Holding AG (9.14), less than AVROBIO, Inc. (26.17), less than Immix Biopharma, Inc. (3.47), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65),

Build a custom stock screener for Freeline Therapeutics Holdings plc (FRLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Freeline Therapeutics Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Freeline Therapeutics Holdings plc (FRLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Freeline Therapeutics Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Freeline Therapeutics Holdings plc's Current Ratio?

How is the Current Ratio calculated for Freeline Therapeutics Holdings plc (FRLN)?

What is the highest Current Ratio for Freeline Therapeutics Holdings plc (FRLN)?

What is the 3-year average Current Ratio for Freeline Therapeutics Holdings plc (FRLN)?

What is the 5-year average Current Ratio for Freeline Therapeutics Holdings plc (FRLN)?

How does the current Current Ratio for Freeline Therapeutics Holdings plc (FRLN) compare to its historical average?